Skip to main content
I

INOVIQ LTD — Investor Relations & Filings

Ticker · IIQ ISIN · AU0000196149 ASX Professional, scientific and technical activities
Filings indexed 855 across all filing types
Latest filing 2024-08-18 Regulatory Filings
Country AU Australia
Listing ASX IIQ

About INOVIQ LTD

https://www.inoviq.com

INOVIQ LTD specializes in the development and commercialization of next-generation exosome and precision diagnostics. The company focuses on innovative solutions for the early detection and monitoring of cancer and other diseases. Its proprietary technology portfolio includes EXO-NET, a high-throughput exosome capture tool designed for research and clinical applications, and the SubB2M platform, which utilizes an engineered protein to detect the pan-cancer biomarker Neu5Gc. The company also provides the hTERT test for bladder cancer monitoring. These technologies facilitate non-invasive liquid biopsy tests aimed at improving patient outcomes through high sensitivity and specificity. The core business activities encompass the creation of diagnostic tools and research reagents for the global healthcare and life sciences sectors, emphasizing precision medicine and early intervention.

Recent filings

Filing Released Lang Actions
EGM and Webinar Broadcast 1 page 206.9KB
Regulatory Filings
2024-08-18 English
Quarterly Activities Report and Appendix 4C - June 2024 9 pages 550.4KB
Regulatory Filings
2024-07-29 English
EGM Proxy Form 3 pages 211.5KB
Regulatory Filings
2024-07-21 English
Notice of Extraordinary General Meeting 16 pages 528.1KB
Regulatory Filings
2024-07-18 English
Application for quotation of securities - IIQ 6 pages 18.4KB
Regulatory Filings
2024-07-08 English
IIQ Options Distribution Schedule and Top 20 Holders 3 pages 113.5KB
Regulatory Filings
2024-07-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.